The QualityStocks Daily Tuesday, February 25th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (IGEN) +76.84%

StockMarketWatch (COCP) +64.66%

The Street (MRNA) +27.81%

The QualityStocks Daily Stock List

Abacus Health Products, Inc. (ABAHF)

Simply Wall St, New Cannabis Ventures, Morningstar, Penny Stock Hub, Cannanbindex.co, OTC Markets, InvestorX, OTC.Watch, Stockhouse, Market Wire News, Dividend Investor, Stockwatch, TradingView, Investors Hangout, Market Screener, TipRanks, and Investing News reported beforehand on Abacus Health Products, Inc. (ABAHF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Abacus Health Products, Inc. manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemp. The Company targets its products at the fast growing markets for topical pain relief and therapeutic skincare. Its products are based on proprietary patent-pending technologies developed by Abacus. The Company was formed with a mission to use CBD hemp extract (Cannabis sativa L) as a conduit to deliver the world’s fastest and most effective pain relief products to millions of people around the world. OTCQB-listed, Abacus Health Products is a subsidiary of Aidance Skincare & Topical Solutions, LLC.

Fundamentally, Abacus Health Products engages in the development and commercialization of OTC registered topical medications with active pharmaceutical ingredients. These contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD (cannabidiol) from the Cannabis sativa L plant.

At present, Abacus offers two lines of products. One is CBD CLINIC™, marketed to the professional practitioner market. The other is CBDMEDIC™, marketed to the consumer market. Its products are offered throughout the U.S. They are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.

Abacus Health Products is the first company to secure OTC registrations for a family of products blended with CBD hemp extract (Cannabis sativa L). In 2016, the Company commenced distribution to healthcare practitioners under the CBD CLINIC brand name. In Q3 of 2018, Abacus launched CBDMEDIC directly to the active fitness and mass retail markets.

CBD CLINIC products are formulated to support fast and lasting relief from joint and muscle pain. A proprietary blend of natural emollients facilitates deeper and faster absorption of pain-relieving compounds to interrupt pain signaling. Furthermore, CBDMEDIC products use only naturally-derived analgesic ingredients and 100 percent natural oils to help accelerate absorption. The CBDMEDIC line is segmented into three product categories: Active Sport, Back & Neck and Arthritis.

Last week, Abacus Health Products announced the launch of its new CBD CLINIC Massage Therapy Series. This is a line of eight new massage oils and creams. The CBD CLINIC Massage Therapy Series has been developed purposely for massage therapists and other Complementary and Alternative Medicine (CAM) practitioners. This product line offers practitioners different levels of strength and also, for the first-time, unscented versions of massage oil and cream.

Mr. Perry Antelman, Chief Executive Officer of Abacus Health Products, said, “CBD CLINIC products were developed to offer health care practitioners solutions that provide superior pain relief for their patients. The Massage Therapy Series offers a newly formulated line developed to address the specific needs of massage therapy practitioners and reflects Abacus’ ability to innovate and develop the highest quality products. We look forward to continuing to lead and support the health care practitioner industry with additional new product introductions in the future.”

Abacus Health Products, Inc. (ABAHF), closed Tuesday's trading session at $3.5, off by 0.290866%, on 1,005 volume with 5 trades. The average volume for the last 3 months is 6,162 and the stock's 52-week low/high is $3.00/$14.00.

chart

Amazing Energy Oil and Gas, Co. (AMAZ)

Proactive Investors, Investor Place, PR Newswire, Digital Journal, Energy Voice, Oil and Gas Investments Bulletin, Money Morning, Nasdaq, wallstreet-online, Tech Know Bits, and OilandGas360 reported beforehand on Amazing Energy Oil and Gas, Co. (AMAZ), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Amazing Energy Oil and Gas, Co. engages in the exploration, development, and production of oil and gas in Texas and East New Mexico. The Company operates leaseholds in the Permian Basin where it holds the rights within a 70,000-acre leasehold in Pecos County, Texas and is surrounded by large independent oil and gas companies. Overall, Amazing controls greater than 75,000 acres between their rights in Pecos County, Texas and assets in Lea County, New Mexico, and Walthall County, Mississippi. The Company also provides oilfield services to oil and gas well owners. The independent oil and gas exploration and production Company is based in Plano, Texas. Amazing Energy Oil and Gas lists on the OTC Markets Group’s OTCQB.

Jilpetco is a wholly-owned subsidiary of Amazing Energy Oil and Gas. Jilpetco is an oilfield services company. It owns and operates drilling, completion, and workers rigs. Jilpetco also leases operational services equipment.

Additionally, Amazing Energy Oil and Gas holds 16,904 gross acres in Lea County, New Mexico that is held by production. The Company primarily engages in the acquisition and exploitation of oil and natural gas properties with an emphasis on well-defined plays containing stacked pay zones such as the San Andres, Devonian, Pennsylvanian and Wolfcamp.

In West Sawyer, Lea County, New Mexico, Company development highlights include 16,904 gross acres; 10,051 net acres; 56 percent average Working Interest (WI) and operatorship. Four horizontal wells have been drilled. Net Production = 32.4 BOPD.

Pertaining to Pecos County, Amazing’s position accounts for rights within 70,000 acres leasehold (about 100 sq. miles); 100 percent WI; 75 percent Net Revenue Interest (NRI). A total of 26 wells have been drilled on the property. These are either producing or in the process of being completed.

Amazing Energy Oil and Gas has acquired assets located in Walthall County, Mississippi known as the Denver Mint Project. The new assets consist of 900 acres of leasehold, 9 oil wells and a saltwater disposal well. These assets include associated production facilities and infrastructure vital to substantially increase the asset's current production profile.

This month, Amazing Energy Oil and Gas announced that it launched a new subsidiary called Amazing Energy Technologies, LLC (AET). It has brought on experienced professional, Mr. Mark Moss to run the new subsidiary as its Chief Executive Officer. The newly created entity will concentrate on the recovery and monetization of stranded natural gas from Amazing's existing assets and neighboring peers who presently either sell at a loss or flare associated gas production in the process of oil recovery.

Amazing Energy Technologies (AET) will address the stranded gas puzzle through delivering associated production and stranded gas to onsite portable units developed to convert gas to electricity and power onboard mining facilities for Bitcoin. It plans to deploy the first units in its Permian Basin acreage in the Summer of 2020.

Amazing Energy Oil and Gas, Co. (AMAZ), closed Tuesday's trading session at $0.10, off by 9.0909%, on 4,500 volume with 3 trades. The average volume for the last 3 months is 30,032 and the stock's 52-week low/high is $0.059999998/$0.373199999.

chart

Bankers Cobalt Corp. (NDENF)

OTC Markets, VentureCapNews, Penny Stock Hub, InvestorX, Streetwise Reports, TalkMarkets, The Prospector News, 4-Traders, Current Charts, Investor Place, Market Screener, Junior Mining Network, Energy and Capital, Stockhouse, PR Newswire, Wallet Investor, TipRanks, Barchart, Dividend Investor, TradingView, Morningstar, GlobeNewswire, Investing Online, Nasdaq, Seeking Alpha, Simply Wall St, and Investors Hub reported previously on Bankers Cobalt Corp. (NDENF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Bankers Cobalt Corp. is a cobalt and copper (Co-Cu) exploration and development enterprise listed on the OTC Markets’ OTCQB. It focuses on advancing its high quality portfolio of permitted concessions in the Democratic Republic of Congo (DRC). Bankers Cobalt is working to produce a reliable, certified, and socially responsible supply of Co-Cu for existing and new processors in the DRC. The Company has its head office in Vancouver, British Columbia.

Bankers Cobalt is building a portfolio of assets that will provide clean, certified, and non-conflict Co-Cu supply in an interdependent relationship with DRC based processors with existing excess capacity and a lack of available certified resources to meet escalating market demands. The Company has a 191 km2 portfolio Co-Cu concessions in the DRC - one of the early movers actively exploring and developing Co-Cu in the DRC. It has a portfolio of 9 concessions strategically positioned with clean title.

Bankers Cobalt’s value proposition includes acquiring, exploring, and developing valuable CO-CU assets worldwide. It also includes selling clean, conflict-free high quality supply to smelters. Furthermore, it includes maintaining ongoing and synergetic relationships with existing smelters. The Company acquires high quality projects in the DRC. It subsequently develops them by applying Canadian standard highly professional exploration techniques.

Bankers Cobalt has its “Concession - Comipad Comima CMTC (ZEA 292).” Ownership is 70/30 JV between the Company and three cooperatives. Its location is 6 km2-35 km southwest of Likasi with access by paved road and tracks.

In August 2019, Bankers Cobalt announced incentive stock option grants and provided a property update. It announced the grant of 512,500 incentive stock options to certain of its Directors, Officers, Consultants and Employees pursuant to its Stock Option Plan. These options are exercisable for a period of five years at a price of CAD$0.05 per share. Insiders of the Corporation cancelled 3,250,000 earlier issued incentive stock options.

Moreover, the Company, further to a news release dated May 15, 2019, and after completion of due diligence, determined to not proceed with the M’Sesa tailings project in the in the DRC. Bankers Cobalt will concentrate on larger near-term copper and cobalt cash flow opportunities in the DRC.

Bankers Cobalt Corp. (NDENF), closed Tuesday's trading session at $0.007, even for the day, on 1,300 volume with 2 trades. The average volume for the last 3 months is 5,983 and the stock's 52-week low/high is $0.002099999/$0.033799998.

chart

Emgold Mining Corporation (EGMCF)

Metals News, Investors Observer, Street Insider, StockScores, TMXmoney, The Newswire, Dividend Investor, MineStat, Seeking Alpha, Mining.com, Stockhouse, GuruFocus, MarketWatch, Investing News, Gold Stock Data, Mining Stock Valuator, OTC Markets, Junior Mining Network, Wallet Investor, Nasdaq, 4-Traders, InvestorsHub, 24hgold, Ceo.ca, Stockwatch, TradingView, Canadian Insider, and Morningstar reported previously on Emgold Mining Corporation (EGMCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Emgold Mining Corporation is a junior gold and base metal exploration company focused on the State of Nevada and the Province of Quebec. Its strategy is to look for quality acquisitions, add value to these assets through exploration, and monetize them through sale, joint ventures (JVs), option, royalty, and other transactions to create value for its shareholders. Emgold Mining looks for strategic acquisitions including quality properties adjacent to existing mines or advanced stage projects; with deeply discounted prices because of length and severity of the present down – a “buyer’s market”; with locational and/or other synergies when coupled together with other projects; and that are easily accessible for low-cost exploration. Emgold Mining is based in Vancouver, British Columbia.

The Company has a strategic share investment in Troilus Gold Corporation (TLG). TLG is advancing the Troilus Gold Project in Quebec. Additionally, Emgold Mining is in the process of acquiring the Mindora Property in Nevada.

Emgold Mining’s properties include the Golden Arrow, New York Canyon, Buckskin Rawhide East, Buckskin Rawhide West, and Koegel Rawhide Properties in Nevada and the Casa South Property in Quebec. The Casa South Property is contiguous to Hecla Mining Corporation's (HL) operating Casa Berardi Mine.

Emgold Mining announced in November of 2019 that it staked 92 additional claims, expanding the size of its earlier optioned New York Canyon Property. The Company now controls 152 unpatented and 21 patented mineral claims in the Santa Fe Mining District, Mineral County, in west-central Nevada. The Property is situated about 30 miles southeast of Hawthorne, Nevada.

Emgold Mining signed an option agreement to acquire a 100 percent interest in the Property from Searchlight Resources, Inc. (SCLT). The acquisition includes a significant database of historic information. To date, 234 holes have been drilled on the Property by past operators, totalling 139,056 feet. Three primary exploration targets have been identified with historic drilling. These include the Longshot Ridge, Champion, and Copper Queen areas. These targets host copper oxide skarn and sulfide porphyry style copper/molybdenum mineralization.

This month, Emgold Mining announced it signed an Earn-In with Option to Joint Venture Agreement with Kennecott Exploration Company, a subsidiary of Rio Tinto PLC (RIO:L) (RIO.AX) (RIO.N), for the New York Canyon Property, Nevada. The Property hosts copper oxide skarn and copper-molybdenum-gold-silver sulfide porphyry mineralization in three known targets - Longshot Ridge, Copper Queen, and Champion. Kennecott can earn up to a 75 percent interest in the Property by completing US$22.5 million in exploration expenditures.

Mr. David Watkinson, President and Chief Executive Officer of Emgold Mining, stated, "The Agreement with Kennecott represents another successful example of Emgold's business strategy of acquiring assets, adding value and monetizing them through sale, option, joint venture or other business transactions. In this case, we are pleased to have Kennecott earn-in and, if successful, become a joint venture partner with Emgold and take the lead to advance New York Canyon."

Furthermore, Kennecott has staked 265 unpatented mineral claims at New York Canyon. This is in addition to Emgold Mining's 152 unpatented mining claims and 21 patented mining claims. The 417 unpatented claims and 21 unpatented claims, totalling roughly 8,700 acres, are now combined under the Agreement and make up the Property.

Emgold Mining Corporation (EGMCF), closed Tuesday's trading session at $0.048, even for the day, on 5 volume. The average volume for the last 3 months is 8,128 and the stock's 52-week low/high is $0.033300001/$0.1444.

chart

Free Flow, Inc. (FFLO)

OTC Markets, Stockhouse, Simply Wall St, Dividend Investor, TipRanks, last10k, Seeking Alpha, 4-Traders, Investors Hangout, Central Charts, TradingView, Street Insider, Market Screener, Stockopedia, GuruFocus, Barchart, Wallet Investor, GlobeNewswire, InvestorsHub, and Nasdaq reported earlier on Free Flow, Inc. (FFLO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Free Flow, Inc. is in the business of new and used auto parts – OEM (Original Equipment Manufacturer) new and recycled. At the 19-plus acre facility in King George, Virginia, the Company by way of its subsidiaries, Motors & Metals, Inc., and Accurate Auto Parts, Inc., disassembles salvaged automobiles and sells pre-sorted automobile parts via a "parts locator network" over the internet that is a very sophisticated Inventory Management System. Free Flow has its head office in King George. The Company’s shares trade on the OTC Markets.

New parts are sourced from different international sources. In addition, Free Flow engages in contract manufacturing and sells a pioneering aerosol that eliminates odor, mold, as well as mildew. The Company’s Motors & Metals subsidiary is a licensed scrap metal processor. Motors & Metals has ongoing orders to ship automobile motors overseas. In addition, it processes catalytic converters for recovery of precious metals.

The Accurate Auto Parts subsidiary plans to build a covered auto recycling - a disassembly, warehousing and shipping facility of used auto parts and tires, at its facility in King George. The location is an existing approved recycling operation. It has existed as a licensed auto wrecking facility for numerous years.

HYGIENIQ.COM is a division of Free Flow. HYGIENiQ™ is a leading-edge sterilizing, deodorizing and air-purifying technology. The Company states that it is the easiest and most effective way to continually sterilize/deodorize/air purify the inside of motor vehicles.

HYGIENiQ™, upon exposure to sunlight, breaks down and eliminates all allergens, odors, and air pollutants in a vehicle, purifying and protecting car interiors for a fresher and healthier driving experience. HYGIENiQ™ harnesses the power of light and advanced nano science photocatalytic technology, to break down odors, allergens and VOC pollutants into harmless inorganic gas and water vapor, completely decomposing and eliminating, not covering up, worse odors.

Free Flow, Inc. (FFLO), closed Tuesday's trading session at $0.55, even for the day, on 1,000 volume. The average volume for the last 3 months is 103 and the stock's 52-week low/high is $0.389999985/$1.25.

chart

Precision Optics Corporation, Inc. (PEYE)

Zacks, Capital Cube, Market Screener, hot Stocked, AI Stock Finder, 4-Traders, GlobeNewswire, PR Newswire, BioSpace, TMXmoney, Barchart, TradingView, Wallet Investor, Simply Wall St, Stockopedia, Investing.com, and Research and Markets reported previously on Precision Optics Corporation, Inc. (PEYE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components. It provides state-of -the-art optics and optical systems for medical, biomedical, and industrial applications. Its inventive medical instrumentation line includes state-of-the-art endoscopes and endocouplers, and custom illumination and imaging products for use in minimally invasive surgical procedures. The Company has been contract manufacturing OEM (original equipment manufacturer) optics components and assemblies for more than 30 years. OTCQB-listed, Precision Optics is headquartered in Gardner, Massachusetts.

The Company’s expertise is providing lenses to sizes as small as 0.2mm in diameter utilizing its proprietary Microprecision™ technology with the quality of ground lenses approaching the cost of gradient index (GRIN) lenses. Precision Optics can design, prototype, and manufacture, under one roof, optical systems and components for imaging of the body's smallest compartments and tissues.

Additionally, the Company has mastered the advanced techniques required to manufacture custom designed prisms. With tolerances to .01mm, it can produce a broad array of prisms to meet clients exacting needs.

Precision Optics also provides optical components, optical system design, and production of different lens and prism products for the defense industry and aerospace industry. As a critical vendor, it can assist a client’s optics development efforts from system design through volume optics fabrication and manufacturing.

The Company’s micro optical, micro mechanical, and electro optical assembly services use Precision’s specialized techniques, tools and fixtures to assemble components in the range of 1 millimeter and smaller. Precision fabricates and assembles components, sub-assemblies, as well as complete endoscopic instruments.

This month, Precision Optics announced operating results on an unaudited basis for its Q2 Fiscal Year ended December 31, 2019. Revenue for the quarter ended December 31, 2019 was $2.8 million versus $1.5 million in the same quarter of the prior Fiscal Year. This represents an increase of 89 percent driven chiefly by Ross Optical operating as a division of Precision Optics. Revenues for both Precision Optics and Ross Optical increased quarter-over-quarter and year-over-year.

The Company had Gross Margins for the quarter ended December 31, 2019 of 33 percent versus 24 percent in the same quarter of the previous year driven mainly by Ross Optical operating as a division of Precision Optics. A Net Loss of $550,825 during the quarter included $274,706 of stock-based compensation.

Precision Optics Corporation, Inc. (PEYE), closed Tuesday's trading session at $1.55, up 1.9737%, on 6,243 volume with 9 trades. The average volume for the last 3 months is 13,950 and the stock's 52-week low/high is $1.04999995/$2.25.

chart

Stillcanna, Inc. (SCNNF)

StockStreetNews, Penny Stock Hub, OTC Markets, Investors Hangout, Stock Target Advisor, GuruFocus, Cannabis Stock Trades, Markets Insider, OTC.Watch, Marijuana Stocks, Morningstar, Market Wire News, Market Screener, Pot Stock News, TradingView, PotStocks.com, MicroSmallCap, TipRanks, Stockwatch, Stockhouse, Dividend Investor, PR Newswire, Accesswire, Seeking Alpha, Wallet Investor, Nasdaq, InvestorsHub, and Barchart reported earlier on Stillcanna, Inc. (SCNNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Stillcanna, Inc. focuses on the cultivation and extraction of hemp biomass into concentrated CBD (cannabidiol) extracts. The Company has established itself internationally as a trusted source for high-grade, premium wholesale CBD products. From its cultivation operations to its state-of-the-art extraction facilities, Stillcanna controls the whole process (Seed-to-CBD). Stillcanna lists on the OTC Markets and the Company is based in Vancouver, British Columbia.

Based on a proprietary process and intellectual property (IP), Stillcanna is forecasted to be one of the lowest-cost CBD extractors operating in Europe. The Company has signed an extraction contract to be the exclusive extractor for Dragonfly BioSciences LLC, a United Kingdom-based supplier of CBD. Upon the completion of the Olimax Transaction, StillCanna will be one of the top processors and providers of market-ready CBD in Europe.

Stillcanna cultivates and sources its biomass exclusively from Hemp Sativa L. This is organically grown using Good Agricultural Practices. Proprietary food-grade ethanol based extraction methods help to ensure high CBD-content in isolate and distillate products. Stillcanna manufactures under GMP standard conditions with EU-compliant hemp cultivars that fall within the designated THC (tetrahydrocannabinol) restrictions.

The Company’s extraction and formulation experts have processed greater than 1,000 batches of CBD employing an ethanol-based extraction process. Under European law, all CBD must be derived from approved hemp cultivars. Importing CBD into the EU with a higher THC content than 0.2 percent is illegal.

This past October, Stillcanna announced that its Polish extraction facility Nexus successfully refined its Distillate oils to the highest possible purity.

Mr. Jason Dussault, Chief Executive Officer of Stillcanna, said, "Stillcanna has always intended to define and refine the future of CBD. We continue to implement our mandate of volume manufacturing while deploying the highest standards of processing and products. Being able to produce such a high quality product puts Stillcanna in a small and elite group of global manufacturers in the seed to CBD supply chain."

Stillcanna, Inc. (SCNNF), closed Tuesday's trading session at $0.1505, even for the day, on 35,107 volume. The average volume for the last 3 months is 65,704 and the stock's 52-week low/high is $0.100699998/$1.00.

chart

Sunshine Biopharma, Inc. (SBFM)

Stockwatch, Investing.com, Real Investment Advice, Trading View, Market Screener, GuruFocus, Stockopedia, Insider Financial, Simply Wall St, Dividend Investor, Wallet Investor, All Stocks, InvestorsHub and Stockhouse reported earlier on Sunshine Biopharma, Inc. (SBFM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sunshine Biopharma, Inc. is a pharmaceutical company listed on the OTC Markets. The Company concentrates on the development of drugs for the treatment of aggressive types of cancer. Furthermore, Sunshine offers generic pharmaceuticals, Essential Brand dietary supplements, and certified analytical chemistry services. Sunshine Biopharma has its corporate office in Pointe-Claire, Quebec.

The Company operates by way of three subsidiaries. These comprise Atlas Pharma, Inc. (Testing Services); Sunshine Biopharma Canada, Inc. (Generic Drugs); and NOX Pharmaceuticals, Inc. (Propriety Drugs). Atlas Pharma offers certified testing services of pharmaceutical and other industrial samples. Generic drugs coming soon from Sunshine Biopharma Canada (not available in the U.S.) include SBI-Anastrozole for treatment of Breast Cancer; SBI-Letrozole for treatment of Breast Cancer; SBI-Bicalutamide for treatment of Prostate Cancer; and SBI-Finasteride for treatment of BPH (Benign Prostatic Hyperplasia).

Regarding Sunshine Biopharma’s Proprietary Drugs in development, the Company’s flagship anticancer drug is Adva-27a. This is a GEM-difluorinated C-glycoside derivative of Podophyllotoxin, targeted for different kinds of cancer. The expectation is that Adva-27a will enter Phase I clinical trials for pancreatic cancer and multidrug resistant breast following completion of the GMP manufacturing and formulation of a 2-kilograms quantity for injection.

Sunshine Biopharma also has its dietary supplements product line - Essential 9™. This product contains all 9 essential amino acids in one tablet for maintaining and building muscle mass. In December of 2018, Sunshine Biopharma completed the development of Essential 9™. On December 14, 2018, Health Canada issued NPN 80089663 through which it authorized the Company to manufacture and sell the Essential 9™ product.

In December 2018, Sunshine Biopharma announced it signed an agreement with Crocus Laboratories Inc., (Montreal) for assistance in the manufacturing of Adva-27a. Crocus will help Sunshine Biopharma in the development of a large-scale process for the manufacturing of 2 to 5 kilograms of Adva-27a. The material, which will ultimately be generated by a contract manufacturing organization, will be used for animal toxicity studies and clinical trials.

Recently, Sunshine Biopharma announced it launched 7 new dietary supplements in addition to its original product, Essential 9™. The new products are BCAA; L-Carnitine; L-Creatine; L-Glutamine; Vitaminax; Omega 3; and Vitamin B12.

Sunshine Biopharma, Inc. (SBFM), closed Tuesday's trading session at $0.0003, up 53.8462%, on 83,508,356 volume with 53 trades. The average volume for the last 3 months is 15,502,948 and the stock's 52-week low/high is $0.000099999/$0.017999999.

chart

Generex Biotechnology Corporation (GNBT)

Stock Twits, Stockhouse, Capital Cube, Investors Hangout, Infront Analytics, Simply Wall St, Biospace, Business Wire, Zacks, Stockwatch, Marketbeat, Baystreet.ca, Dividend Investor, GuruFocus, Insider Financial, InvestorsHub, GlobeNewswire, Market Screener, Trading View, Last10k, MarketWatch, Equity Clock, and Insider Tracking reported earlier on Generex Biotechnology Corporation (GNBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Generex Biotechnology Corporation is an integrated healthcare holding company listed on the OTCQB. It has end-to-end solutions for patient centric care from swift diagnosis through delivery of personalized therapies. The Company is building a new kind of healthcare company, which extends beyond traditional models providing support to physicians in an MSO network, and continuing relationships with patients to improve the patient experience and access to optimum care. Generex Biotechnology is based in Miramar, Florida.

The Company’s newly formed, wholly-owned subsidiary is NuGenerex Distribution Solutions (NDS). It integrates the Company’s MSO network with a pharmacy network, clinical diagnostic lab, durable medical equipment company (DME-IQ) and dedicated call center.

Generex Biotechnology’s corporate mission is to provide physicians, hospitals, and healthcare providers an end-to-end solution for patient centric care This is from fast diagnosis through delivery of personalized therapies, streamlining care processes, minimizing expenses, and delivering transparency for payers.

Generex Biotechnology is advancing a legacy portfolio of immune-oncology assets, medical devices, as well as diagnostics. Nonetheless, it is concentrating on an acquisition strategy of strategic businesses, which complement existing assets and provide immediate sources of revenue and working capital. Its recent acquisitions include a management services organization, a network of pharmacies, clinical laboratory, and medical device companies with new and approved products.

Last week, Generex Biotechnology announced the appointment of Mr. Mark J. Prioletti to the Board of Directors. Mr. Prioletti is a highly experienced marketing and business professional. He has greater than 35 years of success in the wireless communications industry for government, enterprise, and consumer segments in the United States and worldwide markets.

Mr. Prioletti had a distinguished career at Motorola, leading Channel Marketing & Sales, New Program Development, Partnership and Alliance Development to significantly expand the Motorola sales operations that continually generated profitable revenue and growth for developing markets and mature businesses. Mr. Prioletti has exceptionally strong skills in marketing strategy and sales operation.

Generex Biotechnology Corporation (GNBT), closed Tuesday's trading session at $0.6501, off by 17.7661%, on 236,957 volume with 126 trades. The average volume for the last 3 months is 412,186 and the stock's 52-week low/high is $0.224490001/$0.990000009.

chart

Glance Technologies, Inc. (GLNNF)

Connecting Investor, Stock Invest, Wallet Investor, Trading View, InvestorsHub, Emerging Growth, Stockhouse, GuruFocus, Evergreen Caller, MarketWatch, InvestorsHub, and Insider Financial reported previously on Glance Technologies, Inc. (GLNNF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Glance Technologies, Inc. owns and operates Glance Pay. This is a streamlined payment system. Glance Pay transforms how smartphone users choose where to dine, order food and drink, settle bills, access digital receipts, earn premier rewards, and interact with merchants. With the Glance Pay mobile payment application (app), there is no set up or cancellation fees and no system integration or connections required. OTCQB-listed, Glance Technologies is based in Vancouver, British Columbia.

The Glance Pay mobile payment system consists of proprietary technology. This technology includes user apps available for free downloads in IOS (Apple) and Android formats, a merchant manager apps, a large-scale technology hosting environment with sophisticated anti-fraud technology, and very fast payment processing.

The Company offers targeted in-app marketing, social media marketing, customer feedback, in-merchant messaging, and custom rewards programs. The Glance Pay mobile payment app works for full service restaurants, quick serve restaurants (QSRs), retail, and more. Furthermore, the app features easy activation and training, easy automatic accounting and reconciliation, and quick payment deposits.

Glance Technologies’ intention is to apply components of its anti-fraud technology to cryptocurrencies. This is to lessen the risk associated with converting traditional currencies to and from cryptocurrencies. Glance is pursuing opportunities to license its earlier acquired BlockImpact cryptocurrency and blockchain platform as a white label solution.

Glance Technologies has launched its new Pay With Bitcoin feature. Pay With Bitcoin permits Glance Pay users to pair their cryptocurrency wallet with their Glance Pay account, and then buy Glance Dollars with Bitcoin. Glance Dollars represent a credit that can be spent quickly at participating merchants within the Glance Pay ecosystem.

Recently, Glance Technologies announced it officially launched its ‘Real-Time Bill™’ feature to the public at select locations. Numerous other locations are lined up for launch. ‘Real-Time Bill™’ is a pioneering new feature that allows users to view and pay their bill in real time directly from the Glance Pay™ App whenever they are ready to leave, without needing to wait for a paper bill.

This app identifies the user’s bill based on Quick Response (QR) codes or Near-field communication (NFC) tags at their table. The app accesses and settles the appropriate bill in real-time from the merchant’s point of sale (POS) system. ‘Real-Time Bill™’ considerably improves the experience for consumers. Moreover, it enables restaurants to turn their tables over much quicker. The result is greater revenue, lower staffing costs, as well as more satisfied customers.

Glance Technologies, Inc. (GLNNF), closed Tuesday's trading session at $0.29, up 70.5882%, on 1,517,143 volume with 507 trades. The average volume for the last 3 months is 350,368 and the stock's 52-week low/high is $0.0225/$0.38409999.

chart

Beleave, Inc. (BLEVF)

NetworkNewsWire, Research Pool, TradingView, Marketwired, Penny Stock Tweets, OTC Markets, New Cannabis Ventures, Equities, MarketWatch, Morningstar, 4-Traders, Midas Letter, Daily Marijuana Observer, Weed Newswire, Wallet Investor, The Street, InvestorsHub, Business Insider, Investing News, Cannabis Newswire, Investors Hangout, Stockhouse, Barchart, and Primed Equities reported previously on Beleave, Inc. (BLEVF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Beleave, Inc. is a diversified biotechnology company with a purpose-built ACMPR licensed cannabis facility near Hamilton, Ontario. Additionally, the OTCQX-listed Company has patient services clinics operating throughout Ontario under the Medi-Green brand. Its wholly-owned subsidiary is Beleave Kannabis Corp. Beleave earlier closed on the acquisition of the Medi-Green Cannabis Clinic Network. London, Ontario is Beleave’s fourth clinic joining three Ontario locations already open in Hamilton, Kingston, and Perth. Beleave is headquartered in Oakville, Ontario.

Beleave has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market in 2019. Its Hamilton, Ontario laboratory is undergoing expansion to make room for methods to formulate cannabis extracts into soluble, flavorless powders, sugar crystals, and syrups for use in beverages and food products using stability-enhancing techniques for prolonged shelf-life.

The Company’s aim is to provide a consistent, reliable and standardized product to suit the needs of every person. Beleave concentrates on green initiatives. It grows its plants using no pesticides. Furthermore, its facilities host a large-scale, commercial, solar installation that substantially offsets its carbon footprint. Beleave’s water supply is on a closed loop system to recycle every drop.

Beleave’s products include Shishkaberry, CBD god bud, and Cold Creek Kush. Shiskaberryʼs buds have a fruit and berry aroma with shades of purple. CBD god bud was created by mixing an almost pure Sativa strain named Hawaiin with a very strong purple Indica strain. Cold Creek Kush is an Indica-dominant hybrid. It crosses the strong MK Ultra and Chemdawg 91.

In July of 2018, Beleave announced the acquisition of 100 percent of the outstanding shares of Seven Oaks, Inc. This acquisition follows important news of Seven Oaks branded cannabis products being chosen by Manitoba Liquor and Lotteries Corporation and the BC Liquor Distribution Branch for sale to consumers in deals expected to produce initial revenues of more than $2,900,000. Beleave will offer Seven Oaks-branded cannabis flower, pre-rolls, and oils.

Beleave announced this past November that it secured genetics acquisition agreements for a broad assortment of cannabis seed varieties from different lineages. There will be 90 new varieties introduced in 2019. These have been selected to cover the entire spectrum of low, intermediate, and high THC and CBD profiles.

In January of this year, Beleave announced that its wholly-owned subsidiary Beleave Kannabis was authorized by Health Canada to sell cannabis oil products effective January 11, 2019. After reviewing the application and supporting documentation, Health Canada granted an amended license with modified conditions allowing for the sale of cannabis oil under the Cannabis Regulations.

Beleave, Inc. (BLEVF), closed Tuesday's trading session at $0.03, up 101.3423%, on 72,601 volume with 10 trades. The average volume for the last 3 months is 116,990 and the stock's 52-week low/high is $0.0065/$0.092500001.

chart

Nemaura Medical, Inc. (NMRD)

Business Wire, Market Exclusive, Barchart, OTC Markets, Stockhouse, Simply Wall St, InvestorsHub, and 4-Traders reported earlier on Nemaura Medical, Inc. (NMRD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nemaura Medical, Inc. is a medical technology company developing the wireless sugarBEAT® disposable adhesive skin-patch as a non-invasive, needle-free, pain-free, and affordable continuous glucose monitoring (CGM) system for adjunctive use by diabetics. The Company’s patient-friendly technology has the potential to transform health monitoring through providing real-time, tailored feedback on glucose, lactate, as well as other important body performance metrics. Nemaura Medical is based in Loughborough, England.

The Company’s patented  BEAT™  technology  (passing a mild, non-perceptible electric current across the skin)  draws a small number of selected molecules, such as glucose, into a patch placed on the skin. These molecules are drawn out of the interstitial fluid. The patch - by way of a sensor - measures the amount of that molecule present, converting it into a meaningful concentration value for clinical diagnosis or preliminary guidance for self-treatment.

The BEAT™ technology will enable remote continuous monitoring of chronic diseases and health conditions. It is to replace traditional invasive methods of diagnosis and healthcare observation procedures.

The sugarBEAT® App can be pre-downloaded on a user’s smart device. There is an optional sugarBEAT® handheld reader (applicable where a user chooses not to use their own smart device). sugarBEAT®  provides accurate glucose measurement. It consists of a reusable transmitter containing a daily-disposable adhesive skin-patch.

Nemaura Medical announced in July 2018 that it began the first of a number of planned studies in support of a submission to the U.S Food & Drug Administration (FDA) for approval of its sugarBEAT® product. It further announced positive interim results from the home-use portion of this initial study. The anticipation is that the initial U.S. study will enroll 75 patients wearing the device over a 7-day period, including 3 days in a clinical setting (525 total patient days; 225 total in-clinic days). Initial U.S. study completion and FDA submission is anticipated in Q1 2019.

Last week, Nemaura Medical announced that it signed an exclusive license and distribution agreement with Al-Danah Medical Co. This is for the commercial launch of sugarBEAT® in Qatar in readiness for a 2019 launch. Al-Danah Medical Company is part of the Almana Group. Al-Danah is a foremost medical product distributor in Qatar, representing many international brands.

Nemaura Medical, Inc. (NMRD), closed Tuesday's trading session at $5.80, up 76.2918%, on 426,302 volume with 3,076 trades. The average volume for the last 3 months is 8,018 and the stock's 52-week low/high is $2.50/$14.8000001.

chart

IGEN Networks Corp. (IGEN)

NetworkNewsWire.com, MarketWatch, InvestorsHub, Marketwired, OTC Markets, Information Vine, Business Insider, Stock Press Daily, The Street, and Barchart reported on IGEN Networks Corp. (IGEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

IGEN Networks Corp. is a foremost innovator of cloud-based and Internet of Things (IoT) automotive solutions for the protection and management of mobile assets. The Company provides peace-of-mind to automotive consumers and their families via direct access to IoT cloud-based services, which include Stolen Vehicle Protection, Real-time updates on asset health and Driver Behavior. OTCQB-listed and incorporated in 2006, IGEN Networks has its head office in Murrieta, California.

The Company provides vehicle tracking and recovery solutions to the automotive dealership industries in the U.S. IGEN Networks serves the automobile industry through vehicle security services, lot management services, and driver behavior services.

IGEN Networks enables automotive dealer channels to provide new products, create additional revenue streams, as well as keep their customers. The Company provides peace-of-mind to consumers through providing direct access to vehicle status and driver behavior. The Company also enables insurance companies to decrease their rating errors through offering consumers discounted premiums in return for access to vehicle and driver behavior data.

This past October, IGEN Networks announced the launch of Medallion GPS™. Medallion GPS™ is a new, easily installed, direct-to-consumer solution. It combines vehicle agnostic hardware with cloud based smartphone software. This system provides automotive aftermarket customers with a new standard in stolen vehicle recovery support, vehicle systems alerts, driver behavior monitoring and GPS tracking capabilities, in addition to other features.

In November, IGEN Networks announced the filing of its Q3 2017 financial results. The Company increased year-to-date Revenue 26 percent to 1.04 million, boosted by growing adoption of its mobile asset tracking platforms. It grew the subscriber base 264 percent year-over-year, to over 31,000 assets at September 30, 2017.

IGEN increased deferred revenue 146 percent, to $182,000. The Company increased gross margin to 39.2 percent through the first nine months, versus 36.8 percent in the previous year period. It reported a Net Loss of $662,000 year-to-date, excluding stock based compensation expenses, versus $551,000 in the previous year nine-month period.

IGEN Networks Corp. (IGEN), closed Tuesday's trading session at $0.0084, up 76.8421%, on 4,499,353 volume with 74 trades. The average volume for the last 3 months is 239,980 and the stock's 52-week low/high is $0.0046/$0.087499998.

chart

American Power Group Corp. (APGI)

Marketbeat.com, Stock News Now, and SmallCapVoice reported on American Power Group Corp. (APGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. The Company’s alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas® Dual Fuel Conversion Technology for vehicular, stationary, as well as off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts and lists on the OTC Markets Group’s OTCQB.

The Company’s patented Turbocharged Natural Gas® Dual Fuel Conversion Technology is a unique non-invasive software driven solution. It converts existing vehicular and stationary diesel engines to run simultaneously on diesel and different kinds of natural gas. This includes compressed natural gas, liquefied natural gas, conditioned well-head/ditch gas or bio-methane gas with the flexibility to return to 100 percent diesel fuel operation at any time. It is a ground-breaking non-invasive energy enhancement system.

American Power Group (with its proprietary Flare to Fuel™ process technology) can convert captured gases into natural gas liquids (NGLs) that can sell as heating fluids, emulsifiers, or be further processed by refiners. Via the Company’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.

Regarding American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad collection of engine models and end-market applications demands no engine modifications.

Yesterday, American Power Group announced that it will extend the filing of its June 30, 2017 Quarterly Form 10Q through SEC Form 12b-25. The Company announced on June 6, 2017, a corporate wide realignment of its strategic direction, reallocation of resources, and reduction in workforce in response to considerable operating losses because of the effect that ongoing low oil prices were having on its dual fuel and flare capture businesses. The realignment resulted in a decrease in annual operating costs of greater than $2 million on a going forward basis.

American Power Group Corp. (APGI), closed Tuesday's trading session at $0.0098, up 63.3333%, on 29,400 volume with 8 trades. The average volume for the last 3 months is 34,237 and the stock's 52-week low/high is $0.002899999/$0.0986.

chart

The QualityStocks Company Corner

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt Corp. (CSE:BOLT) (OTCQB:PCRCF) (XFRA:NXFE) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 40+ brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, titled “Indonesia Consolidates Nickel Production to Feed Growing EV Battery Market,” visit: http://nnw.fm/9DkyR

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade battery metals deposits within the Asia-Pacific region, employing a vertically integrated “minerals-to-market” strategy to leverage these assets to their fullest.

Pacific Rim Cobalt Corp. is advancing its flagship, 100% controlled Cyclops Nickel-Cobalt located in Papua Province, Indonesia with a mandate to become a key contributor to Asia-Pacific’s rapidly expanding electric vehicle and battery supply chain.

The Cyclops project, uniquely positioned within the world’s largest producer of nickel and in proximity to China, the world’s largest “Gigafactory”, features near surface, strong nickel-cobalt mineralization. The property is situated in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to nickel-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Indonesia has recently approved environmental impact studies for factories to produce battery-grade nickel chemicals in Morowali. The approval will allow investors, such as China’s stainless steel giant Tsingshan Group, to continue the construction of their high-pressure acid leaching plants in Morowali, Central Sulawesi.

Ranjeet Sundher, chief executive officer of Pacific Rim Cobalt, said: “Indonesia continues to make significant strategic decisions, and this latest announcement represents an important step in Pacific Rim Cobalt’s efforts to benefit from Indonesia’s rapid development as a leading market for all stages of the EV supply chain. With offices in Vancouver, Shanghai and Jakarta, Pacific Rim Cobalt is well positioned to leverage Asia’s global dominance in the battery manufacturing sector.”

Indonesia’s commitment extends to the very top of government, with Joko Widodo – Indonesia’s President – stating in September 2019 that “for nickel, we want raw materials to be processed in Indonesia. We want added values”. This supports previous pronouncements from key officials, including Indonesian Maritime Minister, Luhut Pandjaitan who remarked that Indonesia will “become the main player in lithium batteries” and that it will “control the world market”.

The country, which is the world’s top nickel ore exporter, has stopped export of unprocessed nickel ore to support this plan.

During 2019 the Company carried out an extensive exploration and development program on Cyclops and achieved successful nickel results with its drilling and bench-scale scoping tests for processing of materials.

Drilling identified significant horizons of nickel mineralization and bench-scale scoping tests returned positive results for processing of this nickel rich material.

The recovery percentages form the bench-scale test program are set out below (for further information, please refer to the Company’s press release of October 28, 2019):

Sample Nickel (%) Cobalt (%) Iron (%)
Limonite 99.26 98.82 97.77
Low Iron Transition 99.75 97.03 99.22
Saprolite 99.77 >99.9 99.74

 

Selected elevated nickel drill results are provided below from the Company’s shallow drilling program (for further information, please refer to the Company’s press releases of March 5, April 1, April 23, June 13, June 20 and September 10, 2019):

Intersection length (metres from surface) Nickel (%) Cobalt (%)
7.0 2.15% 0.03%
4.0 1.96% 0.04%
2.0 2.00% 0.01%
2.0 1.91% 0.05%

 

2020 will see continued and consistent development in Pacific Rim Cobalt’s strategy as the company continues to set ambitious milestones with the goal of becoming a leading international player in the EV battery metal sector and creating significant long-term shareholder value.

This includes preparations to commission and operate the company’s pilot plant in Canada, which will contain an integrated circuit to produce high-purity nickel and cobalt strip solutions to develop battery-grade nickel and cobalt.

The results of the pilot plant will then be used to establish the design criteria for the subsequent demonstration plant in Indonesia, which will produce nickel and cobalt products suitable to meet market specifications. As well as demonstrating Pacific Rim Cobalt’s ability to produce a product within market specifications, this will also be used to establish the design criteria for the company’s commercial-scale plant.

Pacific Rim Cobalt’s world-class management team includes Ranjeet Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed Tuesday's trading session at $0.1888, up 11.0588%, on 132,843 volume with 26 trades. The average volume for the last 3 months is 27,871 and the stock's 52-week low/high is $0.079999998/$0.259299993.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) on Monday announced that CFO Corey Lambrecht discussed an outline of the company’s direction on the Cleantech and Climate Change Podcast. Lambrecht also discussed unaudited 2019 financial results for SING’s Direct Solar of America subsidiary, which the company acquired in May of 2019. “What I can say is that it finished with a couple million dollars in revenue for that particular year,” SinglePoint CFO Corey Lambrecht stated during the podcast. To listen to the podcast, visit http://nnw.fm/Yfb5U.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Tuesday's trading session at $0.0104, even for the day, on 2,477,671 volume with 108 trades. The average volume for the last 3 months is 4,139,120 and the stock's 52-week low/high is $0.007/$0.023.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

In the wake of a cannabis competitor losing its license, hemp and cannabis food company Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) is reiterating its commitment to quality production as it gears up to launch a new line of products to supplement its already top-selling edibles. PLUS has announced plans to expand its brand portfolio in Q1 2020 as the cannabis-savvy company targets consumers outside of its core demographic (http://cnw.fm/7AcMk).

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Tuesday's trading session at $0.758, off by 2.5832%, on 71,777 volume with 78 trades. The average volume for the last 3 months is 42,097 and the stock's 52-week low/high is $0.674000024/$5.61000013.

Recent News

chart

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) was featured today in the 420 with CNW by CannabisNewsWire. On Thursday, the Kentucky House of Representatives passed legislation legalizing medical marijuana within the state. This comes after the Judiciary Committee voted in the bill last week in a vote of 65-30. The Legislation now proceeds to the state Senate.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Tuesday's trading session at $0.50, off by 5.6604%, on 16,835 volume with 7 trades. The average volume for the last 3 months is 9,047 and the stock's 52-week low/high is $0.400999993/$2.1775.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

As the cannabis industry works to weather 2019’s adverse profit and productivity reports (http://cnw.fm/aqD7t), consumption drug platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)is helping to ensure that product inventories can remain potent and perform at their potential despite a natural tendency for cannabinoids to deteriorate with time.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Tuesday's trading session at $0.4433, off by 3.6304%, on 37,601 volume with 30 trades. The average volume for the last 3 months is 96,998 and the stock's 52-week low/high is $0.3037/$1.52999997.

Recent News

chart

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

Hemp infusion technology innovator MCTC Holdings Inc. (OTC: MCTC) appointed cannabis industry veteran Robert L. Hymers III as its chief financial officer. Previously a director of the company, Hymers has a vast and impressive background in financial planning and analysis, corporate finance, treasury, tax, investor relations, risk management, and strategic planning, according to a company press release (http://cnw.fm/s0oOE).

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Tuesday's trading session at $0.24, off by 20.00%, on 12,452 volume with 9 trades. The average volume for the last 3 months is 17,449 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (CIIX) was featured today in a publication from CBDWire, examining how lupus is an autoimmune disorder where the immune system turns on the body and attacks the tissues and organs. The resulting inflammation wreaks havoc on the entire body, and everything from the skin and lungs to the kidney, heart, and brain are affected. Although there’s currently no cure for the condition, there are a variety of medications that can be used to treat the symptoms. Cannabidiol (CBD) is a chemical extracted from hemp, and it’s taking the medical community by storm. Users say CBD is effective against a range of illnesses from anxiety and insomnia to chronic pain and high blood pressure, and although there’s little research to prove it, they swear by it.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Tuesday's trading session at $0.134, off by 10.6071%, on 53,971 volume with 23 trades. The average volume for the last 3 months is 52,665 and the stock's 52-week low/high is $0.119999997/$0.51999998.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

The biotech sector has been one of the better stock market performers for some time now, and the trend continued in 2020 as well so far. One of the biotech stocks that deserve attention at this point is that of Genprex Inc (NASDAQ: GNPX), which has emerged as the biggest biotech stock gainer since January 17. During the period, the stock has managed to gain as much as 1500% on the back of favorable developments. Hence, it is perhaps important for investors to have a look at the latest developments at Genprex. The Austin based firm announced that it raised as much as $25.5 million by way of two separate stock offerings.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Tuesday's trading session at $6.23, up 3.3167%, on 9,420,165 volume with 31,100 trades. The average volume for the last 3 months is 6,874,837 and the stock's 52-week low/high is $0.231000006/$7.0300002.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood Holdings (OTCQB: NGTF), the better-for-you ice cream company addressing America’s $50 billion-dollar nighttime snacking market, today announced that its ice cream was featured nationally on The Rachael Ray Show on Monday, February 24. Ray spoke with world-renowned sleep expert and Nightfood Scientific Advisor, Dr. Michael Breus, in a segment devoted to sleep. To view the full press release, visit http://nnw.fm/xK0Mu

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving late-night snacking for consumers and solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in the ice cream category in a Kantar survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try.

Nightfood has secured distribution in several major regional supermarket chains and has landed media coverage in major outlets such as The Today Show, The Wall Street Journal, Oprah Magazine, USA Today, The Washington Post, Parents Magazine, and many more.

Over 80% of consumers snack regularly at night, and the most popular choices are cookies, chips, candy, and, of course, ice cream. These are understood to be both unhealthy and sleep-disruptive.

Research indicates that human biological programming combined with the trappings of modern life combine to drive this unhealthy behavior pattern. Every week, hundreds of millions of Americans combine to spend an estimated $1B on snacks consumed between dinner and bed.

In a recent Harris Poll online study, 54% of consumers who snack at night reported often feeling guilty about their nighttime snack choices. 58% said they wish they felt more in control of their nighttime snacking.

Nightfood management believes that the company that solves this massive consumer problem can become a national brand with a billion-dollar valuation.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc. was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company is seeking licensing opportunities to market such products under the brand name “Half-Baked,” for which they’ve successfully secured trademark rights.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former vice president of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Christensen led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small-cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed Tuesday's trading session at $0.425, up 15.1762%, on 790,440 volume with 274 trades. The average volume for the last 3 months is 126,721 and the stock's 52-week low/high is $0.187999993/$0.920000016.

Recent News

chart

Spectrum Global Solutions, Inc. (SGSI)

The QualityStocks Daily Newsletter would like to spotlight Spectrum Global Solutions, Inc. (SGSI).

Spectrum Global Solutions, Inc. (OTCQB: SGSI) (the “Company” or “Spectrum”), a leading single source energy management technology and network services provider, today announced the appointment of Brynjar N. Meling to the Spectrum Board of Directors. Mr. Meling is one of Norway’s most respected and well-known legal experts. He is the Chairman and owner of the Meling AS law firm in Norway, with offices in Stavanger and Oslo.  Mr. Meling previously served as a board member of Spectrum’s WaveTech GmbH subsidiary.

Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:

  • AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
  • ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
  • Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.

Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.

Market Opportunity

Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.

Management

CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.

Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.

Spectrum Global Solutions, Inc. (SGSI), closed Tuesday's trading session at $0.02, up 2.5641%, on 45,915 volume with 6 trades. The average volume for the last 3 months is 107,831 and the stock's 52-week low/high is $0.014999999/$0.300000011.

Recent News

chart

No Borders Inc. (OTC: NBDR)

The QualityStocks Daily Newsletter would like to spotlight No Borders Inc. (NBDR).

No Borders Inc. (OTC: NBDR) was featured today in a publication from HempWireNews, examining how the Coronavirus broke out in Wuhan City, Hubei Province in China in December 2019. As of 23 February, there were 78,987 cases that had been confirmed, and roughly 31,000 of them were from China. The outbreak has put the entire world on alert, with most governments putting screening processes in place to prevent the disease from entering their borders.

No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.

Different by Design

Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.

The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.

With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.

NBDR Companies

  • No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
  • No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
  • No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
  • No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
  • No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.

 

Leadership

No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.

COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.

CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.

Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.

No Borders Inc. (NBDR), closed Tuesday's trading session at $0.02, even for the day, on 15,465 volume with 5 trades. The average volume for the last 3 months is 124,995 and the stock's 52-week low/high is $0.007699999/$0.048799999.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments, today announced that its wholly-owned subsidiary CLR Roasters has forged a new distribution partnership with prestigious distributor Krasdale Foods. In the business for over 100 years, Krasdale Foods distributes over 12,000 grocery item SKUs, services over 2500 retail locations and its geographic footprint includes NYC and metro areas in New York, as well as New Jersey, Connecticut, Pennsylvania, Massachusetts, and Rhode Island. To view the full press release, visit http://cnw.fm/c5v1V

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed Tuesday's trading session at $1.27, off by 3.7879%, on 32,777 volume with 328 trades. The average volume for the last 3 months is 82,355 and the stock's 52-week low/high is $1.25/$7.55000019.

Recent News

chart

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) on Monday released its results for the period ended December 28, 2019. According to the update, Green Growth Brands’ revenues for the period totaled $21.1M. To view the full press release, visit http://cnw.fm/L6sSr

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Tuesday's trading session at $0.22, off by 31.164%, on 4,756,195 volume with 2,012 trades. The average volume for the last 3 months is 407,885 and the stock's 52-week low/high is $0.176200002/$4.48999977.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Hemp infusion technology innovator MCTC Holdings Inc. (OTC: MCTC) appointed cannabis industry veteran Robert L. Hymers III as its chief financial officer. Previously a director of the company, Hymers has a vast and impressive background in financial planning and analysis, corporate finance, treasury, tax, investor relations, risk management, and strategic planning, according to a company press release (http://cnw.fm/s0oOE). Previously, Hymers was CFO and Director of Marijuana Company of America, Inc. (OTCQB: MCOA), and brings with him a deep understanding of the hemp and cannabis industries.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Tuesday's trading session at $0.032, off by 15.2318%, on 4,430,153 volume with 201 trades. The average volume for the last 3 months is 1,064,614 and the stock's 52-week low/high is $0.023/$1.13999998.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.